Role of chemokines in tumor growth.

Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS One (2010) 6.61

Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol Med (2010) 3.10

Immunotherapy of cancer in 2012. CA Cancer J Clin (2012) 2.12

Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models. Int J Cancer (2011) 2.01

Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Mol Cell Proteomics (2010) 1.97

Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells. Oncogene (2009) 1.69

Chemokines in health and disease. Exp Cell Res (2011) 1.69

Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1beta. J Biol Chem (2009) 1.67

Peptides and peptide hormones for molecular imaging and disease diagnosis. Chem Rev (2010) 1.63

Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer. Neoplasia (2011) 1.56

High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma. Br J Cancer (2009) 1.55

Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling. Cell Death Differ (2013) 1.49

Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival. BMC Cancer (2015) 1.48

The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients. J Hematol Oncol (2015) 1.40

CXCR4/CXCL12 axis in non small cell lung cancer (NSCLC) pathologic roles and therapeutic potential. Theranostics (2013) 1.35

Targeting IL-17B-IL-17RB signaling with an anti-IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines. J Exp Med (2015) 1.35

The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers. PLoS One (2009) 1.29

Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease. Inflamm Bowel Dis (2008) 1.28

Breast-cancer-associated metastasis is significantly increased in a model of autoimmune arthritis. Breast Cancer Res (2009) 1.25

The Chemokine CXCL8 in Carcinogenesis and Drug Response. ISRN Oncol (2013) 1.22

The good and the bad of chemokines/chemokine receptors in melanoma. Pigment Cell Melanoma Res (2009) 1.18

High-throughput secretomic analysis of single cells to assess functional cellular heterogeneity. Anal Chem (2013) 1.16

TNFα-exposed bone marrow-derived mesenchymal stem cells promote locomotion of MDA-MB-231 breast cancer cells through transcriptional activation of CXCR3 ligand chemokines. J Biol Chem (2010) 1.16

CXCR4 and matrix metalloproteinase-1 are elevated in breast carcinoma-associated fibroblasts and in normal mammary fibroblasts exposed to factors secreted by breast cancer cells. Mol Cancer Res (2009) 1.09

Immunoglobulin G Fc N-glycan profiling in patients with gastric cancer by LC-ESI-MS: relation to tumor progression and survival. Glycoconj J (2011) 1.08

Chemokine signaling directs trunk lymphatic network formation along the preexisting blood vasculature. Dev Cell (2012) 1.08

Interleukin-8 associates with adhesion, migration, invasion and chemosensitivity of human gastric cancer cells. World J Gastroenterol (2012) 1.07

Tyrosine kinase inhibitors: Multi-targeted or single-targeted? World J Clin Oncol (2011) 1.06

CXCR4/SDF1 mediate hypoxia induced chondrosarcoma cell invasion through ERK signaling and increased MMP1 expression. Mol Cancer (2010) 1.05

Inhibition of stromal CXCR4 impairs development of lung metastases. Cancer Immunol Immunother (2012) 1.03

Adipocyte-released insulin-like growth factor-1 is regulated by glucose and fatty acids and controls breast cancer cell growth in vitro. Diabetologia (2012) 1.03

Primary tumours modulate innate immune signalling to create pre-metastatic vascular hyperpermeability foci. Nat Commun (2013) 1.02

Inflammasomes in cancer: a double-edged sword. Protein Cell (2014) 1.01

DiR-labeled Embryonic Stem Cells for Targeted Imaging of in vivo Gastric Cancer Cells. Theranostics (2012) 1.01

Pancreatic adenocarcinoma upregulated factor promotes metastasis by regulating TLR/CXCR4 activation. Oncogene (2010) 1.01

Perspectives on tissue interactions in development and disease. Curr Mol Med (2010) 1.00

The carboxyl-terminal PDZ ligand motif of chemokine receptor CXCR2 modulates post-endocytic sorting and cellular chemotaxis. J Biol Chem (2008) 1.00

Chemokines and the microenvironment in neuroectodermal tumor-host interaction. Semin Cancer Biol (2008) 0.99

Epigenetics underpinning the regulation of the CXC (ELR+) chemokines in non-small cell lung cancer. PLoS One (2011) 0.99

CXCL12 chemokine expression suppresses human pancreatic cancer growth and metastasis. PLoS One (2014) 0.99

Interleukin-1β promotes ovarian tumorigenesis through a p53/NF-κB-mediated inflammatory response in stromal fibroblasts. Neoplasia (2013) 0.98

CAPC negatively regulates NF-κB activation and suppresses tumor growth and metastasis. Oncogene (2011) 0.98

Mesenchymal stem cells promote mammary cancer cell migration in vitro via the CXCR2 receptor. Cancer Lett (2011) 0.98

Benzo[a]pyrene diol epoxide stimulates an inflammatory response in normal human lung fibroblasts through a p53 and JNK mediated pathway. Carcinogenesis (2010) 0.97

Biomarkers in Osteosarcoma. Expert Opin Med Diagn (2009) 0.97

One cell, multiple roles: contribution of mesenchymal stem cells to tumor development in tumor microenvironment. Cell Biosci (2013) 0.97

CXCL9 induces chemotaxis, chemorepulsion and endothelial barrier disruption through CXCR3-mediated activation of melanoma cells. Br J Cancer (2010) 0.96

Hepatitis B virus X protein upregulates mTOR signaling through IKKβ to increase cell proliferation and VEGF production in hepatocellular carcinoma. PLoS One (2012) 0.96

Polarized dendritic cells as cancer vaccines: directing effector-type T cells to tumors. Semin Immunol (2010) 0.95

Identification of the bacterial protein FtsX as a unique target of chemokine-mediated antimicrobial activity against Bacillus anthracis. Proc Natl Acad Sci U S A (2011) 0.95

CXCL16 and CXCR6 are coexpressed in human lung cancer in vivo and mediate the invasion of lung cancer cell lines in vitro. PLoS One (2014) 0.94

Curcumin inhibits COPD-like airway inflammation and lung cancer progression in mice. Carcinogenesis (2009) 0.94

LIM and SH3 protein-1 modulates CXCR2-mediated cell migration. PLoS One (2010) 0.94

Osteoblasts are a major source of inflammatory cytokines in the tumor microenvironment of bone metastatic breast cancer. J Cell Biochem (2010) 0.94

Targeting CXCR2 enhances chemotherapeutic response, inhibits mammary tumor growth, angiogenesis, and lung metastasis. Mol Cancer Ther (2013) 0.93

Chemokine receptor CXCR2: physiology regulator and neuroinflammation controller? J Neuroimmunol (2012) 0.93

Suppression of neuroblastoma growth by dipeptidyl peptidase IV: relevance of chemokine regulation and caspase activation. Oncogene (2008) 0.92

Hypoxia differentially regulated CXCR4 and CXCR7 signaling in colon cancer. Mol Cancer (2014) 0.91

Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challenges. Front Immunol (2015) 0.91

Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients. Am J Hematol (2012) 0.91

CXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2 and activation of MEK and PI3K pathways. Mol Biol Cell (2014) 0.90

CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma. J Exp Clin Cancer Res (2015) 0.90

The role of adipose-derived stem cells in breast cancer progression and metastasis. Stem Cells Int (2015) 0.90

Acetyl-11-keto-β-boswellic acid suppresses invasion of pancreatic cancer cells through the downregulation of CXCR4 chemokine receptor expression. Int J Cancer (2011) 0.89

CXCR7 is induced by hypoxia and mediates glioma cell migration towards SDF-1α. BMC Cancer (2013) 0.89

A penalized robust method for identifying gene-environment interactions. Genet Epidemiol (2014) 0.88

Reciprocal communication between endometrial stromal cells and macrophages. Reprod Sci (2010) 0.88

Activation of VCAM-1 and its associated molecule CD44 leads to increased malignant potential of breast cancer cells. Int J Mol Sci (2014) 0.88

Rgs2 mediates pro-angiogenic function of myeloid derived suppressor cells in the tumor microenvironment via upregulation of MCP-1. PLoS One (2011) 0.87

CXCR2: a target for pancreatic cancer treatment? Expert Opin Ther Targets (2013) 0.87

Recently identified biomarkers that promote lymph node metastasis in head and neck squamous cell carcinoma. Cancers (Basel) (2011) 0.86

Dendritic cells in cancer immunotherapy: vaccines or autologous transplants? Immunol Res (2011) 0.86

Stromal cell-derived factor-1/CXCL12 contributes to MMTV-Wnt1 tumor growth involving Gr1+CD11b+ cells. PLoS One (2010) 0.86

Downregulation of the CXCR4 receptor inhibits cervical carcinoma metastatic behavior in vitro and in vivo. Int J Oncol (2014) 0.85

Vascular CXCR4 expression - a novel antiangiogenic target in gastric cancer? PLoS One (2010) 0.85

CXCR2-Dependent Endothelial Progenitor Cell Mobilization in Pancreatic Cancer Growth. Transl Oncol (2011) 0.85

Contribution of bone marrow derived cells to the pancreatic tumor microenvironment. Front Physiol (2013) 0.85

Cancer immunoediting from immunosurveillance to tumor escape in microvillus-formed niche: a study of syngeneic orthotopic rat bladder cancer model in comparison with human bladder cancer. Neoplasia (2010) 0.85

CCR7 mediates directed growth of melanomas towards lymphatics. Microcirculation (2011) 0.85

Modulating the interaction of CXCR4 and CXCL12 by low-molecular-weight heparin inhibits hepatic metastasis of colon cancer. Invest New Drugs (2010) 0.84

CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis. Oncotarget (2015) 0.84

Single-cell protein secretomic signatures as potential correlates to tumor cell lineage evolution and cell-cell interaction. Front Oncol (2013) 0.83

Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology Group. Invest New Drugs (2014) 0.83

Green tea polyphenol epigallocatechin-3-gallate suppresses melanoma growth by inhibiting inflammasome and IL-1β secretion. Biochem Biophys Res Commun (2011) 0.83

Role of the tumor microenvironment in the pathogenesis of gastric carcinoma. World J Gastroenterol (2014) 0.83

The immune signature of CD8(+)CCR7(+) T cells in the peripheral circulation associates with disease recurrence in patients with HNSCC. Clin Cancer Res (2012) 0.83

Optimal management of bone metastases in breast cancer patients. Breast Cancer (Dove Med Press) (2011) 0.83

Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers. Mol Oncol (2014) 0.82

Prognostic molecular biomarkers for cutaneous malignant melanoma. J Surg Oncol (2011) 0.82

To NFκB or not to NFκB: The Dilemma on How to Inhibit a Cancer Cell Fate Regulator. Transl Med UniSa (2012) 0.82

The First Type III Domain of Fibronectin is Associated with the Expression of Cytokines within the Lung Tumor Microenvironment. J Cancer (2011) 0.82

Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopes. MAbs (2014) 0.82

Discovery and computer aided potency optimization of a novel class of small molecule CXCR4 antagonists. PLoS One (2013) 0.81

Inflammatory breast cancer: New factors contribute to disease etiology: A review. J Adv Res (2013) 0.81

In vitro migration of cytotoxic T lymphocyte derived from a colon carcinoma patient is dependent on CCL2 and CCR2. J Transl Med (2011) 0.81

Adipose microenvironment promotes triple negative breast cancer cell invasiveness and dissemination by producing CCL5. Oncotarget (2016) 0.81

Human bone marrow mesenchymal stem cells induce collagen production and tongue cancer invasion. PLoS One (2013) 0.80

Targeting chemokine pathways in esophageal adenocarcinoma. Cell Cycle (2014) 0.79

Expression of C-X-C chemokine receptor types 1/2 in patients with gastric carcinoma: Clinicopathological correlations and significance. Oncol Lett (2012) 0.79

Polymorphisms in chemokine and receptor genes and gastric cancer risk and survival in a high risk Polish population. Scand J Gastroenterol (2010) 0.79

The hallmarks of cancer. Cell (2000) 113.05

Inflammation and cancer. Nature (2002) 53.78

Inflammation and cancer: back to Virchow? Lancet (2001) 27.40

Involvement of chemokine receptors in breast cancer metastasis. Nature (2001) 26.07

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med (2004) 22.96

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med (1991) 19.46

Fibroblasts in cancer. Nat Rev Cancer (2006) 18.95

Nuclear factor-kappaB in cancer development and progression. Nature (2006) 18.31

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell (2005) 18.20

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol (2002) 17.85

IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell (2004) 15.82

Chemokines: a new classification system and their role in immunity. Immunity (2000) 13.03

Chemokines--chemotactic cytokines that mediate inflammation. N Engl J Med (1998) 12.80

Putting tumours in context. Nat Rev Cancer (2001) 12.37

Stromal fibroblasts in cancer initiation and progression. Nature (2004) 11.69

Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res (1999) 11.32

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature (1996) 11.21

Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature (1996) 10.67

Cancer and the chemokine network. Nat Rev Cancer (2004) 10.27

TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science (2004) 10.23

Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer (2005) 10.06

The biology of chemokines and their receptors. Annu Rev Immunol (2000) 9.81

Role of angiogenesis in tumor growth and metastasis. Semin Oncol (2002) 9.77

Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol (2007) 9.37

VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell (2006) 9.32

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature (1996) 9.25

Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell (2005) 9.06

Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res (1999) 8.63

Human chemokines: an update. Annu Rev Immunol (1997) 8.43

Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci U S A (2004) 7.96

Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci U S A (2001) 7.93

Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci U S A (1998) 7.69

Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature (1989) 7.30

A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med (2006) 6.86

Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol (1993) 6.55

Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol (2006) 5.82

Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer (2006) 5.60

Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature (2003) 5.57

The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem (2005) 5.45

Two genetic hits (more or less) to cancer. Nat Rev Cancer (2001) 5.19

Inflammation and cancer: how hot is the link? Biochem Pharmacol (2006) 5.17

Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol (2004) 5.07

The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem (1995) 4.77

Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle (2006) 4.67

Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood (2000) 4.34

Species- and cell type-specific requirements for cellular transformation. Cancer Cell (2004) 4.25

Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today (1998) 4.21

Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol Ther (2006) 4.20

Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat Med (2003) 4.02

Cancer: an inflammatory link. Nature (2004) 3.88

Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res (2000) 3.86

A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). Blood (2005) 3.85

Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature (2000) 3.81

Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med (2003) 3.71

The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity. J Immunol (2000) 3.26

Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol (1999) 3.15

Know thy neighbor: stromal cells can contribute oncogenic signals. Curr Opin Genet Dev (2001) 3.12

Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch. Cell Cycle (2006) 3.10

Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science (1990) 3.02

The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J Clin Invest (1995) 3.00

CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc Natl Acad Sci U S A (1999) 3.00

The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am J Respir Crit Care Med (2003) 2.91

Nf-kappa B, chemokine gene transcription and tumour growth. Nat Rev Immunol (2002) 2.81

Chemokines and cancer. Int J Cancer (2006) 2.75

The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. Cancer Res (2007) 2.71

Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res (2002) 2.71

Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta. J Immunol (2007) 2.69

Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2. J Biol Chem (2002) 2.67

The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis. Proc Natl Acad Sci U S A (2006) 2.64

Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha. Int J Cancer (2000) 2.64

Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J Natl Cancer Inst (2001) 2.64

Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression. Nat Med (2006) 2.57

Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma. Cancer (2001) 2.51

Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer (2006) 2.50

Chemokines in cancer. Cytokine Growth Factor Rev (2002) 2.47

IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J Immunol (1993) 2.44

A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature (1997) 2.44

Role of the stromal microenvironment in carcinogenesis of the prostate. Int J Cancer (2003) 2.43

Inflammatory cells and cancer: think different! J Exp Med (2001) 2.42

Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha. Am J Pathol (1999) 2.38

CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res (2005) 2.38

Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer. J Immunol (2004) 2.34

CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. J Exp Med (2006) 2.30

The role of chemokines in melanoma tumor growth and metastasis. J Invest Dermatol (2002) 2.27

Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-beta. Science (1990) 2.22

NSAIDs and cancer prevention: targets downstream of COX-2. Annu Rev Med (2007) 2.19

Inability of Rous sarcoma virus to cause sarcomas in the avian embryo. Nature (1984) 2.18

Autocrine production of IL-10 mediates defective IL-12 production and NF-kappa B activation in tumor-associated macrophages. J Immunol (2000) 2.17

Role of CXCL1 in tumorigenesis of melanoma. J Leukoc Biol (2002) 2.13

Functions of CXCL12 and CXCR4 in breast cancer. Cancer Lett (2005) 2.11

Tumour necrosis factor-alpha as a tumour promoter. Eur J Cancer (2006) 2.09

Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins. Int J Cancer (1997) 2.08

Cancer and aging: a model for the cancer promoting effects of the aging stroma. Int J Biochem Cell Biol (2002) 2.08

Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. Cancer Res (2005) 2.06

Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer. Clin Cancer Res (2005) 2.05

Chemokines, chemokine receptors, and cancer metastasis. J Leukoc Biol (2006) 2.03

Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. Cancer Res (2007) 2.02

Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A. Blood (2004) 1.99

The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity. Cancer Res (2002) 1.99

Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles. Oncogene (2004) 1.97

Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell (2008) 6.78

Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol Med (2010) 3.10

Mouse xenograft models vs GEM models for human cancer therapeutics. Dis Model Mech (2008) 2.37

CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. J Exp Med (2006) 2.30

Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials. PLoS One (2012) 2.21

Constitutive activation of Akt/protein kinase B in melanoma leads to up-regulation of nuclear factor-kappaB and tumor progression. Cancer Res (2002) 2.19

Role of CXCL1 in tumorigenesis of melanoma. J Leukoc Biol (2002) 2.13

Effects of flow and diffusion on chemotaxis studies in a microfabricated gradient generator. Lab Chip (2005) 2.11

The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity. Nat Immunol (2008) 2.08

A novel NF-kappa B-inducing kinase-MAPK signaling pathway up-regulates NF-kappa B activity in melanoma cells. J Biol Chem (2001) 1.94

Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes. J Leukoc Biol (2005) 1.80

Rab11-family interacting protein 2 and myosin Vb are required for CXCR2 recycling and receptor-mediated chemotaxis. Mol Biol Cell (2004) 1.70

Chemokines in health and disease. Exp Cell Res (2011) 1.69

Chemokine receptor internalization and intracellular trafficking. Cytokine Growth Factor Rev (2005) 1.59

NF-kappaB activation in melanoma. Pigment Cell Res (2006) 1.55

BMS-345541 targets inhibitor of kappaB kinase and induces apoptosis in melanoma: involvement of nuclear factor kappaB and mitochondria pathways. Clin Cancer Res (2006) 1.54

Augmenting chemosensitivity of malignant melanoma tumors via proteasome inhibition: implication for bortezomib (VELCADE, PS-341) as a therapeutic agent for malignant melanoma. Cancer Res (2004) 1.51

The Duffy antigen modifies systemic and local tissue chemokine responses following lipopolysaccharide stimulation. J Immunol (2006) 1.50

Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer. Cancer Res (2010) 1.45

Role of nuclear factor-kappa B in melanoma. Cancer Metastasis Rev (2005) 1.41

Differential regulation of CXCR2 trafficking by Rab GTPases. Blood (2002) 1.38

Monomeric and dimeric CXCL8 are both essential for in vivo neutrophil recruitment. PLoS One (2010) 1.29

Conditional ablation of Ikkb inhibits melanoma tumor development in mice. J Clin Invest (2010) 1.28

NF-κB inducing kinase: a key regulator in the immune system and in cancer. Cytokine Growth Factor Rev (2010) 1.28

Parallel phosphatidylinositol 3-kinase (PI3K)-dependent and Src-dependent pathways lead to CXCL8-mediated Rac2 activation and chemotaxis. J Biol Chem (2008) 1.25

Altered CXCR2 signaling in beta-arrestin-2-deficient mouse models. J Immunol (2005) 1.25

CXC chemokines and their receptors: a case for a significant biological role in cutaneous wound healing. Histol Histopathol (2008) 1.23

Systemic targeting inhibitor of kappaB kinase inhibits melanoma tumor growth. Cancer Res (2007) 1.19

The role of chemokines in intestinal inflammation and cancer. Curr Opin Pharmacol (2009) 1.16

VASP is a CXCR2-interacting protein that regulates CXCR2-mediated polarization and chemotaxis. J Cell Sci (2009) 1.13

Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cells. Eur Cytokine Netw (2007) 1.13

Deletion of the COOH-terminal domain of CXC chemokine receptor 4 leads to the down-regulation of cell-to-cell contact, enhanced motility and proliferation in breast carcinoma cells. Cancer Res (2006) 1.12

Targeting aurora kinases limits tumour growth through DNA damage-mediated senescence and blockade of NF-κB impairs this drug-induced senescence. EMBO Mol Med (2012) 1.10

RAF265 inhibits the growth of advanced human melanoma tumors. Clin Cancer Res (2012) 1.09

The angiostatic activity of interferon-inducible protein-10/CXCL10 in human melanoma depends on binding to CXCR3 but not to glycosaminoglycan. Mol Ther (2004) 1.06

The IL sequence in the LLKIL motif in CXCR2 is required for full ligand-induced activation of Erk, Akt, and chemotaxis in HL60 cells. J Biol Chem (2006) 1.05

Hsc/Hsp70 interacting protein (hip) associates with CXCR2 and regulates the receptor signaling and trafficking. J Biol Chem (2001) 1.02

The carboxyl-terminal PDZ ligand motif of chemokine receptor CXCR2 modulates post-endocytic sorting and cellular chemotaxis. J Biol Chem (2008) 1.00

Potential role for Duffy antigen chemokine-binding protein in angiogenesis and maintenance of homeostasis in response to stress. J Leukoc Biol (2002) 1.00

PAK1 kinase is required for CXCL1-induced chemotaxis. Biochemistry (2002) 0.99

Opposing roles of murine duffy antigen receptor for chemokine and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth. Cancer Res (2007) 0.98

A phase I trial of bortezomib with temozolomide in patients with advanced melanoma: toxicities, antitumor effects, and modulation of therapeutic targets. Clin Cancer Res (2009) 0.98

Antioxidants tiron and N-acetyl-L-cysteine differentially mediate apoptosis in melanoma cells via a reactive oxygen species-independent NF-kappaB pathway. Free Radic Biol Med (2007) 0.97

Impaired healing of nitrogen mustard wounds in CXCR2 null mice. Wound Repair Regen (2003) 0.97

RhoB plays an essential role in CXCR2 sorting decisions. J Cell Sci (2007) 0.96

Fine tuning the transcriptional regulation of the CXCL1 chemokine. Prog Nucleic Acid Res Mol Biol (2003) 0.96

LIM and SH3 protein-1 modulates CXCR2-mediated cell migration. PLoS One (2010) 0.94

The chemokine receptors CXCR1 and CXCR2 couple to distinct G protein-coupled receptor kinases to mediate and regulate leukocyte functions. J Immunol (2012) 0.92

Microfluidic switching system for analyzing chemotaxis responses of wortmannin-inhibited HL-60 cells. Biomed Microdevices (2008) 0.92

The lymphotoxin-beta receptor is an upstream activator of NF-kappaB-mediated transcription in melanoma cells. J Biol Chem (2008) 0.91

CXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2 and activation of MEK and PI3K pathways. Mol Biol Cell (2014) 0.90

The dynamic yin-yang interaction of CXCR4 and CXCR7 in breast cancer metastasis. Breast Cancer Res (2012) 0.88

Expression of activated Akt in benign nevi, Spitz nevi and melanomas. J Cutan Pathol (2007) 0.87

IQGAP1 is a novel CXCR2-interacting protein and essential component of the "chemosynapse". PLoS One (2011) 0.87

In situ analysis of breast cancer progression in murine models using a macroscopic fluorescence imaging system. Lasers Surg Med (2006) 0.87

Functional characterization of chimpanzee cytomegalovirus chemokine, vCXCL-1(CCMV). Virology (2007) 0.86

The C-terminal domain LLKIL motif of CXCR2 is required for ligand-mediated polarization of early signals during chemotaxis. J Cell Sci (2004) 0.86

INK4a/ARF [corrected] inactivation with activation of the NF-κB/IL-6 pathway is sufficient to drive the development and growth of angiosarcoma. Cancer Res (2012) 0.85

Molecular determinants of melanoma malignancy: selecting targets for improved efficacy of chemotherapy. Mol Cancer Ther (2009) 0.85

Passage-dependent cancerous transformation of human mesenchymal stem cells under carcinogenic hypoxia. FASEB J (2013) 0.84

Preparation of (-)-Nutlin-3 using enantioselective organocatalysis at decagram scale. J Org Chem (2013) 0.84

Unligated Okazaki Fragments Induce PCNA Ubiquitination and a Requirement for Rad59-Dependent Replication Fork Progression. PLoS One (2013) 0.84

CCAAT displacement protein regulates nuclear factor-kappa beta-mediated chemokine transcription in melanoma cells. Melanoma Res (2007) 0.83

Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology Group. Invest New Drugs (2014) 0.83

Cell surface heparan sulfate participates in CXCL1-induced signaling. Biochemistry (2003) 0.83

Bimodal analysis reveals a general scaling law governing nondirected and chemotactic cell motility. Biophys J (2010) 0.81

Chemokine research moves on. Exp Cell Res (2011) 0.79

Short tail with skin lesion phenotype occurs in transgenic mice with keratin-14 promoter-directed expression of mutant CXCR2. J Leukoc Biol (2008) 0.79

Adaptor protein2 (AP2) orchestrates CXCR2-mediated cell migration. Traffic (2014) 0.78

Chemokines, macrophage inflammatory protein-2 and stromal cell-derived factor-1α, suppress amyloid β-induced neurotoxicity. Toxicol Appl Pharmacol (2011) 0.78

Acute Inhibition of MEK Suppresses Congenital Melanocytic Nevus Syndrome in a Murine Model Driven by Activated NRAS and Wnt Signaling. J Invest Dermatol (2015) 0.78

Micrometastatic Dormancy in Uveal Melanoma: A Comprehensive Review of the Evidence, Mechanisms, and Implications for Future Adjuvant Therapies. Int Ophthalmol Clin (2017) 0.75

The Meharry-Vanderbilt-Tennessee State University Cancer Partnership (MVTCP): History and Highlights of 20 Years of Accomplishments. J Health Care Poor Underserved (2022) 0.75